| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 17.00 +9.47% on 04/04/25 |
Period Open: 18.07
| 18.68 -0.37% on 04/23/25 | +0.54 (+2.99%) since 03/21/25 |
| 3-Month | 17.00 +9.47% on 04/04/25 |
Period Open: 18.38
| 20.50 -9.22% on 03/07/25 | +0.23 (+1.25%) since 01/23/25 |
| 52-Week | 16.55 +12.45% on 04/26/24 |
Period Open: 16.74
| 22.50 -17.29% on 12/20/24 | +1.87 (+11.18%) since 04/23/24 |
Howard G Roberts, a director at $AFBI ($AFBI), sold 703 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.8% of their shares....
Howard G Roberts, a director at $AFBI ($AFBI), sold 222 shares of the company on 11-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares....
Affinity Bancshares, Inc. (NASDAQ:“AFBI”) (the “Company”), the holding company for Affinity Bank (the “Bank”), today announced net income of $1.7 million for the three months ended March 31,...
Affinity Bancshares, Inc. (NASDAQ:“AFBI”) (the “Company”), the holding company for Affinity Bank (the “Bank”), today announced net income of $1.7 million for the three months ended December...
Affinity Bancshares, Inc. (the “Company”), the holding company for Affinity Bank, today announced that its Board of Directors has adopted a second stock repurchase program. Under the repurchase program,...
Affinity Bancshares, Inc. (NASDAQ:“AFBI”) (the “Company”), the holding company for Affinity Bank (the “Bank”), today announced net income of $1.9 million for the three months ended September...
Affinity Bancshares, Inc. (NASDAQ:“AFBI”) (the “Company”), the holding company for Affinity Bank (the “Bank”), today announced net income of $1.8 million for the three months ended June 30,...
Affinity Bancshares, Inc. (NASDAQ:“AFBI”) (the “Company”), the holding company for Affinity Bank (the “Bank”), today announced net income of $1.8 million for the three months ended March 31,...
Affinity Bancshares, Inc. (NASDAQ:“AFBI”) (the “Company”), the holding company for Affinity Bank (the “Bank”), today announced net income of $7.6 million for the year ended December 31, 2021...
Affinity Bancshares, Inc. (the “Company”), the holding company for Affinity Bank, today announced that its Board of Directors has adopted a stock repurchase program. Under the repurchase program, the...
Sitting in 64th position in Barchart’s Bottom 100 Stocks to Buy is Innovate Corp., a penny stock controlled by one of the Glazer family, the owners of the Tampa Bay Bucs and controlling shareholders...
/CNW/ - Aimia Inc. (TSX: AIM) ("Aimia"), a holding company focused on long-term global investments, announced today that it has appointed Suzanne ("Suzi")...
/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment...
/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment of Dr....
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President,...
/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...
/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...
Sitting in 64th position in Barchart’s Bottom 100 Stocks to Buy is Innovate Corp., a penny stock controlled by one of the Glazer family, the owners of the Tampa Bay Bucs and controlling shareholders...
/CNW/ - Aimia Inc. (TSX: AIM) ("Aimia"), a holding company focused on long-term global investments, announced today that it has appointed Suzanne ("Suzi")...
/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment...
/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment of Dr....
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President,...
/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...
/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...
Sitting in 64th position in Barchart’s Bottom 100 Stocks to Buy is Innovate Corp., a penny stock controlled by one of the Glazer family, the owners of the Tampa Bay Bucs and controlling shareholders...
/CNW/ - Aimia Inc. (TSX: AIM) ("Aimia"), a holding company focused on long-term global investments, announced today that it has appointed Suzanne ("Suzi")...
/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment...
/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment of Dr....
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President,...
/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...
/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...
| 3rd Resistance Point | 18.79 |
| 2nd Resistance Point | 18.62 |
| 1st Resistance Point | 18.52 |
| Last Price | 18.61 |
| 1st Support Level | 18.25 |
| 2nd Support Level | 18.08 |
| 3rd Support Level | 17.98 |
| 52-Week High | 22.50 |
| Fibonacci 61.8% | 20.23 |
| Fibonacci 50% | 19.53 |
| Fibonacci 38.2% | 18.82 |
| Last Price | 18.61 |
| 52-Week Low | 16.55 |
